SpringerProtocols: Abstract: 11. Genetic Counseling and Molecular Testing

11. Genetic Counseling and Molecular Testing

By: Lauren Kerzin-Storrar²

Abstract

Full Text

Download PDF (852K)

The provision of genetic counseling should be an Integral component to molecular diagnostic testing for two important reasons: The potential impact (medical and psychosocial) for the individual being tested and for their family is great (1) and ensuring informed choice is crucial as uptake of genetic testing varies between conditions and may be <10% (2–4). Many people, once counseled, choose not to be tested, and this choice might be lost if counseling is not provided. Genetic counseling is comprehensive and includes:

1.	Diagnosis and discussion of prognosis;
2.	Explanation of the mode of inheritance and recurrence risks;
3.	Discussion of options, including reproductive and testing;
4.	Facilitating decision making; and
5.	Support toward adjusting to the genetic tmphcatrons.

Affiliation(s): (2) Department of Medical Genetics, St. Mary’s Hospital, Manchester, UK

Book Title: Molecular Diagnosis of Genetic Diseases

Series: Methods in Molecular Medicine | Volume: 5 | Pub. Date: Jul-19-1996 | Page Range: 205-217 | DOI: 10.1385/0-89603-346-5:205

Subject: Molecular Medicine

References

Download References

1.	Andrews, L. B., Fullarton, J. E, Holtzman, N. A., and Motulsky, A G. (eds.) (1994) Assessing Genetic Risks. Impllcations for Health and Social Policy, National Academy Press, Washington, DC.

2.	Craufurd, D., Kerzm-Stonar, L., Dodge, A., and Harrrs, R. (1989) Uptake of presymptomatic predictive testing for Huntington’s disease. Lancet 2, 603–605.

3.	Hodgkmson, K. A., Kerzm-Storrar, L., Watters, E. A., and Harris, R. (1990) Adult polycystic kidney disease: knowledge, experience and attitudes to prenatal diagnoses. J. Med. Genet. 27, 552–558.

4.	Kerzm-Storrar, L., Khan, A. A., Watters, E. A., Craufiud, D., et al. (1991) A regional genetic family register. Am. J. Hum. Genet 49, 42.

5.	Walker, A. P., Scott, J A., Biesecker, B. B., Conover, B., Blake, W., and Djurdjinovtc, L (1990) Report of the 1989 Asllomar meeting on education in genetic counselling. Am J. Hum. Genet. 46, 1223–1230.

6.	Kerzin-Storrar, L. (1993) A new MSc course in genetic counselling for non-medical co-workers in clmrcal genetics. J Genet Counsellzng 2, 44.

7.	Hans, H., Scotcher, D., Hartley, N., Wallace, A, Craufurd, D., and Harris, R. (1993) Cysttc fibrosis carrrer testing in early pregnancy by general practitioners. Br Med. J 306, 1580–1583.

8.	Wooldndge, E. Q. and Murray, R. F. (1989) The health orientation scale: a measure of feeling about sickle cell trait. Sot. Biol. 35, 123–136.

9.	Tyler, A., Walker, R., Went, L., and Wexler, N. (1994) Guidelines for the molecular genetics predictive test in Huntington’s disease. Clinical practice in medical genetics. J. Med. Genet. 31, 555–559.

10.	Zeesman, S., Glow, C. L., Cartrer, L., and Striver, C. R. (1984) A private view of heterozygosity: eight-year follow-up on carriers of Tay-Sachs gene detected by high school screening. Am. J. Med Genet l8, 769–778.

11.	Marteau, T. M., van Duijn, M., and Ellis, I. (1992) Effects of genetic screening on perceptions of health: a pilot study. J Med Genet. 29, 24–26.

12.	Mitchell, J., Scrrver, C. R., Clow, C. L., and Kaplan, F. (1993) What young people thmk and do when the option for cystic fibrosis carrier testing is available. J. Med Genet 30, 538–542.

13.	Read, A. P., Kerzin-Storrar, L., Mountford, R. C., Elles, R. G., and Harris, R. (1986) A register based system for gene tracking in Duchenne muscular dystrophy. J Med Genet. 23, 581–586.

14.	Abramsky, L. and Chapple, J. (eds.) (1994) Prenatal Dzagnoszs The Human Side, Chapman and Hall, London.

15.	Benjamin, C. M., Colley, A., Donnai, D., Kingston, H., Harris, R., and Kerzm-Storrar, L. (1993) Neurofibromatosis type 1: knowledge, experrence, and reproductive decisions of affected patients and families. J. Med. Genet 30, 567–574.

16.	Faulkner, C., Clancy, T., and Kingston, H. (1995) A study investigating the knowledge, views and experience of myotonic dystrophy (MD) among a group of affected women (poster, autumn 1995), Clinical Genetics Socrety, London.

17.	Firth, H. V., Boyd, P. A., Chamberlain, P. F., MacKenzie, I. Z., Morriss-Kay, G. M., and Huson, S. M. (1994) Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 343, 1069–1071.

18.	Nuffield Council on Bioethics (1993) Genetzc Screenzng Ethzcal Issues, Author, London.

19.	Clarke, A., Fielding, D., Kerzin-Storrar, L., Middleton-Price, H., Montgomery, J., Payne, H., Simonoff, E., and Tyler, A. (1994) The genetic testing of children: report of a working party of the Clinical Genetics Society (UK). J. Med Genet. 31, 785–797.

20.	Dalby, S. (1995) GIG response to the UK Clmical Genetics Society report “The genetic testing of children.” J. Med. Genet. 32, 490–494.

21.	British Medical Association (1995) The BMA’s Views on Genetic Testing, Author, London.

22.	Friedrich, E. (1994) Caring for the carers, in Prenatal Diagnosis The Human Side (Abramsky, L. and Chapple, J., eds.), Chapman and Hall, London, pp. 202–212.

Comments (Loading...)

Post comment/View all comments